METANDREN Drug Patent Profile
✉ Email this page to a colleague
When do Metandren patents expire, and what generic alternatives are available?
Metandren is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in METANDREN is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metandren
A generic version of METANDREN was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METANDREN?
- What are the global sales for METANDREN?
- What is Average Wholesale Price for METANDREN?
Summary for METANDREN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Patent Applications: | 4,401 |
| DailyMed Link: | METANDREN at DailyMed |
US Patents and Regulatory Information for METANDREN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
